С. В. Борисевич
About
In The Last Decade
С. В. Борисевич
58 papers receiving 370 citations
Peers
Comparison fields: 5 of 85
- Infectious Diseases 266
- Epidemiology 80
- Molecular Biology 58
- Neurology 49
- Immunology 30
Countries citing papers authored by С. В. Борисевич
This map shows the geographic impact of С. В. Борисевич's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by С. В. Борисевич with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites С. В. Борисевич more than expected).
Fields of papers citing papers by С. В. Борисевич
This network shows the impact of papers produced by С. В. Борисевич. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by С. В. Борисевич. The network helps show where С. В. Борисевич may publish in the future.
Co-authorship network of co-authors of С. В. Борисевич
This figure shows the co-authorship network connecting the top 25 collaborators of С. В. Борисевич. A scholar is included among the top collaborators of С. В. Борисевич based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with С. В. Борисевич. С. В. Борисевич is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 0 | |
| 5 | 2 | |
| 6 | 2 | |
| 7 | 0 | |
| 8 | 1 | |
| 9 | 1 | |
| 10 | 16 | |
| 11 | 0 | |
| 12 | 1 | |
| 13 | 1 | |
| 14 | 0 | |
| 15 | [Cowpox: features of spread after cancellation of mandatory pox immunization]. | 2 |
| 16 | Therapeutic Efficacy of Triazavirin, a Novel Russian Chemotherapeutic, Against Influenza Virus A (H5N1) | 8 |
| 17 | [Interferon inductor cupping of postvaccinal complications after variolation]. | 1 |
| 18 | [Prophylactic and therapeutic efficacies of Ingavirin, a novel Russian chemotherapeutic, with respect to influenza pathogen A (H5N1)]. | 4 |
| 19 | [Therapeutic efficacy of Ingavirin, a new domestic formulation against influenza A virus (H3N2)]. | 8 |
| 20 | [Antiviral activity of arbidol and its derivatives against the pathogen of severe acute respiratory syndrome in the cell cultures]. | 133 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.